Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
International Journal of Cancer|April 27, 2016
Growing tumors induce a local STING dependent Type I IFN response in dendritic cellsLisa Andzinski, Julia Spanier, Nadine Kasnitz, et al.Journal of Clinical Medicine|March 18, 2020
Impaired Release of Neutrophil Extracellular Traps and Anemia-Associated T Cell Deficiency in Hereditary Hemorrhagic TelangiectasiaFreya Droege, Ekaterina Pylaeva, Elena Siakaeva, et al.Plos One|August 21, 2009
Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alphaSara Leschner, Kathrin Westphal, Nicole Dietrich, et al.Journal of Clinical Medicine|July 13, 2024
Increased Risk for Infections and Allergic Disease in Hereditary Hemorrhagic TelangiectasiaFreya Droege, Jochem König, Karl S Lang, et al.Cells|March 10, 2022
Evaluation of Immunoregulatory Biomarkers on Plasma Small Extracellular Vesicles for Disease Progression and Early Therapeutic Response in Head and Neck CancerJadwiga Jablonska, Malwina Rist, Ilona Spyra, et al.International Journal of Cancer|December 1, 2015
Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and humanLisa Andzinski, Nadine Kasnitz, Stephanie Stahnke, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 17, 2016
In Vivo Visualizing the IFN-β Response Required for Tumor Growth Control in a Therapeutic Model of Polyadenylic-Polyuridylic Acid AdministrationDavid Andrés Nocera, Emiliano Roselli, Paula Araya, et al.Molecular Medicine (Cambridge, Mass.)|May 24, 2023
Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patientsLuisa Tengler, Julia Schütz, Moritz Tiedtke, et al.International Journal of Cancer|November 9, 2021
SIRT1-mediated deacetylation of FOXO3a transcription factor supports pro-angiogenic activity of interferon-deficient tumor-associated neutrophilsSharareh Bordbari, Britta Mörchen, Ekaterina Pylaeva, et al.Blood|August 5, 2010
In vivo RNAi-mediated silencing of TAK1 decreases inflammatory Th1 and Th17 cells through targeting of myeloid cellsGabriel Courties, Virginia Seiffart, Jessy Presumey, et al.Pageof 6